[1] |
沈晓明,王卫平.儿科学[M].7 版.北京:人民卫生出版社,2008,390-391.
|
[2] |
赵婷,李红健,孙岩,等.新疆不同民族癫痫患儿HLA-B~*1502基因多态性与芳香族ASMs 诱导的皮肤不良反应相关性研究[J].药物流行病学杂志,2023,32(2):151-157.
|
[3] |
蔡艳霞,马萍萍,李定.52 例重症药疹患者临床分析[J].皮肤性病诊疗学杂志,2020,27(2):108-111.
|
[4] |
Shi YW,Wang J,Min FL,et al.HLA Risk Alleles in Aromatic AntiepilepticDrug-InducedMaculopapularExanthema[J].Front Pharmacol,2021,12:671572.
|
[5] |
Shafeng N,Han DF,Ma YF,et al.Association between the HLA-B*1502 gene and mild maculopapular exanthema inducedbyantiepilepticdrugsinNorthwestChina[J].BMCNeurol,2021,21(1):340.
|
[6] |
Zhao T,Li HJ,Wang TT,et al.Association between HLA genotype and antiseizure medications(ASMs)-induced maculopapular eruption among epilepsy patients in Xinjiang,China[J].Epilepsy Res,2020,165:106391.
|
[7] |
Moon J,Kim TJ,Lim JA,et al.HLA-B*40:02 and DRB1*04:03 are risk factors for oxcarbazepine-induced maculopapular eruption[J].Epilepsia,2016,57(11):1879-1886.
|
[8] |
Chang BL,Liu JR,Chang SH,et al.Impact on carbamazepine usage and cutaneous adverse reactions before and after the reimbursement of HLA-B*1502 genotyping in Taiwan,2000-2017:A nationwide longitudinal study[J].Epilepsia,2023,64(10):2679-2689.
|
[9] |
Zaccara G,Franciotta D,Perucca E.Idiosyncratic adverse reactions to antiepileptic drugs[J].Epilepsia,2007,48(7):1223-1244.
|
[10] |
刘宏尉,陈叶莉.重症药疹不良反应44 例分析[J].临床合理用药,2024,17(3):165-168.
|
[11] |
Chen Z,Liew D,Kwan P.Effects of a HLA-B*15:02 screening policy on antiepileptic drug use and severe skin reactions[J].Neurology,2014,83(22):2077-2084.
|
[12] |
Liao WP,Shi YW,Min FL,et al.HLA-B*1502 screening and toxic effects of carbamazepine[J].N Engl J Med,2011,365(7):672-673.
|
[13] |
Mehta TY,Prajapati LM,Mittal B,et al.Association of HLAB*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians[J].Indian J Dermatol Venereol Leprol,2009,75(6):579-582.
|
[14] |
民福利,王晓,范翠霞,等.奥卡西平导致的皮肤不良反应与HLA-B*1502、HLA-B*1301 基因的关系[J].实用医学杂志,2021,37(16):2080-2083,2088.
|
[15] |
吴喜萍,谢国民,王海峰,等.宁波地区癫痫患者抗癫痫药物治疗中出现的皮疹与HLA-B*1502、HLA-A*3101基因的关系[J].现代实用医学,2020,32(10):1190-1192.
|
[16] |
Ihtisham K,Ramanujam B,Srivastava S,et al.Association of cutaneous adverse drug reactions due to antiepileptic drugs with HLA alleles in a North Indian population[J].Seizure,2019,66:99-103.
|
[17] |
Spina Tensini T,de Paola L,Boldt ABW,et al.HLA alleles and antiseizure medication-induced cutaneous reactions in Brazil:A case-control study[J].HLA,2023,102(3):269-277.
|
[18] |
Kloypan C,Koomdee N,Satapornpong P,et al.A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions:Implication for Clinical Pharmacogenomics and Precision Medicine[J].Pharmaceuticals(Basel),2021,14(11):1077.
|
[19] |
何娜,宋旺,刘晓蓉,等.HLA-A、B 基因型与卡马西平、奥卡西平致斑丘疹的相关性分析[J].癫痫杂志,2022,8(2):108-115.
|
[20] |
李堂雪,李会婷,吴妍,等.HLA-B 基因多态性与抗癫痫药拉莫三嗪致皮肤不良反应关系的meta 分析[J].中国现代应用药学,2024,41(1):126-132.
|